BioCardia, Inc. (BCDA) NASDAQ
1.20
+0.04(+3.45%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.20
+0.04(+3.45%)
Currency In USD
| Market Cap | 8.33M |
| Enterprise Value | 6.37M |
| P/E Ratio | -1.57 |
| PEG Ratio | -0.06 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 14.42 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.63 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -2.41 |
| Return On Equity | -283.72 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -505,000 |
| EBITDA | -7.77M |
| Net Income | -8.23M |
| Diluted EPS | -1.23 |
| Total Cash | 2.5M |
| Total Cash/Share | 0.23 |
| Total Debt | 528,000 |
| Total Debt/Equity | 0.59 |
| Current Ratio | 1.12 |
| Book Value Per Share | 0.08 |
| 52-Week Change | -40.3 |
| 52-Week High | 3.2 |
| 52-Week Low | 1 |
| Moving Average 50 Days | 1.22 |
| Moving Average 200 Days | 1.55 |
| Average Volume | 68,335 |
| Shares Outstanding | 5.8M |
| % Held by Institutions | 0.04 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:15 |
| Last Split Date | May 30, 2024 |